On Target: Targeting What Matters in Testing is a podcast dedicated to exploring the evolving landscape of diagnostics and its critical role in the development of precision healthcare. Testing is at the center of healthcare like never before, thanks to advancements in genomic sequencing, AI-driven diagnostics, biomarker-driven therapies, and home testing. Healthcare systems are adapting to integrate these technologies effectively, and regulators are trying to keep pace with innovation. Co-hosted by industry experts, On Target features conversations with testing company and laboratory executives, innovators, and thought leaders who are shaping the future of healthcare through testing products and services. In the time it takes to drink your coffee, we’ll let you know where the field is going next.
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
30%
Guest openness
Selective
Sign up to generate a grounded pitch for On Target Podcast.
Signup to Generate a PitchOn Target: Targeting What Matters in Testing is a podcast dedicated to exploring the evolving landscape of diagnostics and its critical role in the development of precision healthcare. Testing is at the center of healthcare like never before, thanks to advancements in genomic sequencing, AI-driven diagnostics, biomarker-driven therapies, and home testing.
Recent episodes include "A pan-cancer liquid biopsy - On Target Podcast w/ Megan Hall, SVP, Global Medical Affairs at GRAIL" (21 October 2026, 51 minutes), "The current and future state of the medical diagnostics industry - On Target Podcast w/ Jack Meehan, Co-Founder and Analyst of Operon Research" (29 September 2026, 40 minutes), and "A liquid biopsy that includes information about the tumor microenvironment - On Target Podcast w/ Mirna Jarosz, CEO, LiquidCellDx" (22 September 2026, 29 minutes).
On Target Podcast publishes roughly every two weeks, with episodes averaging 33 minutes across 20 episodes.
Booking probability for On Target Podcast is 30%, and the host is rated Selective on guests. On Target Podcast requires a Pod Score of 80 or higher. On Target Podcast's contact route on record: verified email.
The strongest fits for On Target Podcast are Medical Labs & Imaging. On Target Podcast has a news audience.
On Target Podcast is a news podcast with 20 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Episode #21
Megan Hall, senior vice president for global medical affairs at GRAIL, explains how her company's test works to detect early cancer and its tissue of origin.
Jack Meehan, co-founder and analyst at Operon Research, talks about the where the diagnostics industry is now and where he sees it heading.
Mirna Jarosz, CEO of LiquidCellDx, explains how her company's liquid biopsy captures information about the tumor microenvironment, providing critical treatment guidance.
Ajit Singh, CEO of Harbinger Health, explains how his company's diagnostic determines whether a patient with nonspecific clinical signs has cancer.
Bob Wassman, chief medical officer and executive vice president of clinical affairs at MARABio, explains how testing for maternal auto-antibodies can drive early autism diagnosis and treatment.
Suchi Saria, founder and CEO of Bayesian Health, tells us about her company's sepsis-detection system - and how to successfully bring such a system into the clinic.
Connie Lehman, founder and CEO of Clairity, shares how AI-driven insights can improve early detection, personalize screening, and ultimately change the future of breast-cancer care.
Madhuri Hegde, SVP and CSO of Revvity, discusses how her company leverages partnerships and broad expertise in both life sciences and diagnostics to solve patient problems.
<p>Janet Woodcock, distinguished FDA veteran and past deputy commissioner of the agency, gives us her take on AI, companion diagnostics, drugs for rare diseases, and how to earn trust for new technology.<br> </p>
Janet Woodcock, distinguished FDA veteran and past deputy commissioner of the agency, gives us her take on AI, companion diagnostics, drugs for rare diseases, and how to earn trust for new technology.
<p>Madhuri Hegde, SVP and CSO of Revvity, discusses how her company leverages partnerships and broad expertise in both life sciences and diagnostics to solve patient problems.</p>
<p>Connie Lehman, founder and CEO of Clairity, shares how AI-driven insights can improve early detection, personalize screening, and ultimately change the future of breast-cancer care.<br> </p>
<p>Dawn Mattoon, CEO of Mercy Bioanalytics, explains how her company is using extracellular vesicles to successfully diagnose early stage cancer.</p>
<p>Doug Biehn, President and CEO of Octave Biosciences, talks about the difference that a biomarker test can make in the management of multiple sclerosis.</p>
<p>Alec Ford, CEO of Karius, shares how genomics and AI are expanding what's possible in infectious disease diagnostics — and why getting the right answer faster can make all the difference for immunocompromised...
<p>Irene Ghobrial, founder of Predicta Biosciences, explains how bringing whole-genome sequencing into the clinic is taking diagnosis and treatment of multiple myeloma and blood cancers to a new level of precision.</p>
<p>Alka Chaubey, CMO of Bionano Genomics, explains how optical genome mapping addresses the unmet needs of cytogenomics - and what it takes to get pathbreaking new technology into the clinic.</p>
Episode #4
<p>Susan Tousi, CEO of DELFI Diagnostics, shares how her company is using AI and fragmentomics to make liquid biopsy more accessible and cancer less deadly.</p>
<p>James Lu, co-founder and CEO of Helix, tells us what his company is doing to make genomics part of the standard portfolio of health-care data.<br> </p>
Episode #2
<p>Julia Cheek, founder and CEO of Everlywell, shares how her company is working to change not only the way people access, use, and understand home tests, but the way home tests fit into the entire landscape of...
Recent guests on On Target Podcast. Study who booked and why before you pitch.
South Carolina National Guard LGBTQ special emphasis program member, Creighton University
Operon Research
LiquidCellDx
Harbinger Health
PitchCentric classifies On Target Podcast under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
LabReflex
Genetics for Healthcare
Agilent “Dialogues in CDx” Podcast Series
Beyond The Result
Pathology News
Diagnostics Decoded by ZeptoMetrix
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ